Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Jan 06, 2023 11:17am
275 Views
Post# 35206911

RE:RE:RE:RE:RE:RE:RE:RE:January 9th warrants

RE:RE:RE:RE:RE:RE:RE:RE:January 9th warrants
ScienceFirst wrote:

Probably that the company wanted to respect those that participated in the original pp of 2019, and so, we're supportive of the company's future, when the Company was looking for funds.  Financing a biotech that has no ph. 2 data at that moment never puts management in the driver's seat when it comes to looking for fundings at the best conditions.

I assume that those that are insulted about this extension would probably also have felt betrayed if they had took part of the 2019 pp and that the company would not have extended those warrants yesterday.

It all depend on where one sits. 

These warrants have been part of the fully diluted share count since Jan. 2019.  

Again, TLT would be in a much better condition if COVID-19 never happened.   But that's life.



________________

 

The Warrants were issued on January 9, 2019 pursuant to a private placement involving the issuance of 4,095,157 units of the Company. The Warrants were previously amended to extend the original expiry date of January 9, 2021 to January 9, 2023. Now, the Company proposes to extend the amended expiry date of January 9, 2023 to January 9, 2024.

 

Yes ScienceFirst this is the 2nd warrant extension the previous was extended from October 3/2022 to October 3/2023. Both extended by 1 year to those that put money into the company for use that has benefited us all. Maybe some are apposed to this but yes it has to me a strong writing on the wall message,  that message is  " we're here baby " reward time is an eye blink away.
<< Previous
Bullboard Posts
Next >>